BrainStorm Announces Groundbreaking Pre-Clinical Study of NurOwn® derived Exosome-Based Treatment for COVID-19 ARDS

July 24, 2020 Leave a comment

BrainStorm Cell Therapeutics Inc, a leading developer of adult stem cell therapies for neurodegenerative diseases, announced today that it has successfully completed its first milestone in developing an innovative exosome-based platform-technology for the treatment severe COVID-19 infection. COVID-19 induced pneumonia ...

Exosome RNA Exosome RNA Research & Industry News

Tag Archives: NurOwn®

BrainStorm Announces Groundbreaking Pre-Clinical Study of NurOwn® derived Exosome-Based Treatment for COVID-19 ARDS

CRISPR used to find cancer biomarkers in exosomes

Biological Dynamics, Perlmutter Cancer Center at NYU Langone Health collaborate on pancreatic cancer research

ExoSponge – rapid, cost-effective, porous polydimethylsiloxane (PDMS) based cancer-associated extracellular vesicle isolation

Technological challenges of biomembrane-coated top-down cancer nanotherapy

Isolation and characterisation of exosomes from Chinese hamster ovary (CHO) cells

Cell-Based Drug Delivery Systems with Innate Homing Capability as a Novel Nanocarrier Platform